The impact of vitamin D on fetal and neonatal lung maturation. A systematic review

Sine Lykkedegn1, Grith Lykke Sorensen2, Signe Sparre Beck-Nielsen1

  • 1Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark; Clinical Institute, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark;

Insights

Vitamin D may improve lung development in preterm infants. Animal studies show positive effects, suggesting vitamin D deficiency could be a risk factor for respiratory distress syndrome and bronchopulmonary dysplasia.

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Nutritional Science

Background:

  • Respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) are significant complications of preterm birth.
  • Pregnancy is often associated with hypovitaminosis D (vitamin D deficiency).

Purpose of the Study:

  • To systematically review the evidence on vitamin D's impact on fetal lung development, surfactant synthesis, RDS, and BPD.
  • To evaluate vitamin D's potential role as a modifiable risk factor for these neonatal respiratory complications.

Main Methods:

  • A systematic literature search was conducted in PubMed, Embase, and Cochrane databases.
  • Included studies comprised human, animal, and laboratory investigations examining vitamin D and lung health outcomes.

Main Results:

  • Human studies provided limited evidence, preventing definitive conclusions.
  • Animal and laboratory studies demonstrated significant beneficial effects of vitamin D on alveolar type II cells, fibroblast proliferation, surfactant synthesis, and alveolarization.
  • No association was found between BPD and vitamin D receptor polymorphism in fully adjusted analyses.

Conclusions:

  • Hypovitaminosis D may be a frequent, modifiable risk factor for RDS and BPD.
  • Further randomized controlled trials are warranted to test vitamin D interventions in pregnant women and preterm neonates.
  • Future research should determine optimal vitamin D dosages and timing for preventing adverse respiratory outcomes.

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
9.1K
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
886
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.8K